Interestingly, gossypin, differing from gossypetin by a β-D-glucopyranosyl residue attached at position 8, was reported to inhibit NF-κB activation in KBM-5 myeloid leukemia cells under the same conditions reported for gossypetin [75]. This evidence concerns the gene NFKB1 and myeloid leukemia.